For the year ending 2025-12-31, UTHR has $7,880M in assets. $783.8M in debts. $1,557.1M in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 1,557.1 | |||
| Marketable investments | 1,363.2 | |||
| Accounts receivable, no allowance for 2025 and 2024 | 350.2 | |||
| Inventories, net | 183.1 | |||
| Other current assets | 248.9 | |||
| Total current assets | 3,702.5 | |||
| Marketable investments | 1,776.7 | |||
| Goodwill and other intangible assets, net | 116.5 | |||
| Property, plant, and equipment, net | 1,729.7 | |||
| Deferred tax assets, net | 357.7 | |||
| Other non-current assets | 196.9 | |||
| Total assets | 7,880 | |||
| Accounts payable and accrued expenses | 488 | |||
| Line of credit | 0 | |||
| Other current liabilities | 72.6 | |||
| Total current liabilities | 560.6 | |||
| Other non-current liabilities | 223.2 | |||
| Total liabilities | 783.8 | |||
| Preferred stock, par value .01, 10,000,000 shares authorized, no shares issued | 0 | |||
| Common stock, par value .01, 245,000,000 shares authorized, 76,452,253 and 74,997,896 shares issued, and 43,643,165 and 44,831,306 shares outstanding as of december 31, 2025 and 2024, respectively | 0.8 | |||
| Additional paid-in capital | 2,798 | |||
| Accumulated other comprehensive income (loss) | 0.9 | |||
| Treasury stock, 32,809,088 and 30,166,590 shares as of december31, 2025 and 2024, respectively | 4,260.4 | |||
| Retained earnings | 8,556.9 | |||
| Total stockholders equity | 7,096.2 | |||
| Total liabilities and stockholders equity | 7,880 | |||
UNITED THERAPEUTICS Corp (UTHR)
UNITED THERAPEUTICS Corp (UTHR)